BACKGROUND AND PURPOSE:While the number of CTA examinations is continually increasing compared with DSA examinations, there is little comparative dose information about the different imaging techniques. We compared patient radiation exposure resulting from diagnostic CTA and DSA examinations for both cerebral and cervicocerebral vessels.

The applicability of radiophotoluminescence dosimetry was determined by assessing various radiophotoluminescence dosemeter (RPLD) properties for measuring medical radiation doses from radiation sources of a continuous spectrum. The RPLD was found to be accurate for measuring doses in diagnostics (50-125 keV) and radiation therapy (6, 10 and 18 MV photons, 6 and 15 MeV electrons). The RPLD shows excellent dose linearity (R(2) > 0.99), reproducibility and batch uniformity, and minimal fading and accurate accumulated dose measurement. The dosemeter material is independent of photon energy in the diagnostic range; however, the dosemeter requires additional calibration in the mammography energy range and also for accurate dose measurement with photon or electron energies in radiation therapy. RPLD measurements with a tin filter show considerable angular dependence at angles exceeding 50° between the photon beam and the normal to the long axis of the dosemeter. The RPLD measurement accuracy at high doses can be improved with optimised pre-heating schemes.

The aim of the study was to compare the absorbed doses and image quality of organ-based tube current modulation (OBTCM) and bismuth shielding of breasts and thyroid against regular tube current modulation in chest CT scan. An anthropomorphic phantom and MOSFET dosemeters were used to evaluate absorbed doses. Image quality was assessed from HU and noise. Relative to the reference scan, the average absorbed dose reduction with OBTCM was 5.2% and with bismuth shields 24.2%. Difference in HU values compared to the reference varied between −4.1 and 4.2 HU in OBTCM scan and between −22.2 and 118.6 HU with bismuth shields. Image noise levels varied between 10.0 to 26.3 HU in the reference scan, from 9.6 to 27.7 HU for the OBTCM scan and from 11.9 to 43.9 HU in the bismuth scan. The use of bismuth shields provided greatest dose reduction compared to the investigated OBTCM.

This study revealed that the AD to the fetus due to the endovascular method can be reduced to be below the risk for developmental disorders when pulsed fluoroscopy with an optimized protocol is used without angiography exposures.